| COVID-19 |
0 |
0.95 |
| Otolaryngology |
0 |
0.93 |
| Cancer |
0 |
1 |
| Breast Cancer |
0 |
0.79 |
| Head and Neck Cancer |
0 |
0.74 |
| Biologic Therapy |
0 |
0.72 |
| Colorectal Cancer |
0 |
0.71 |
| Pancreatic Cancer |
0 |
0.68 |
| Cancer Survivor |
0 |
0.61 |
| Nasopharyngeal Cancer |
0 |
0.61 |
| Rectal Cancer |
0 |
0.61 |
| Dorsum |
0 |
0.34 |
| Healthcare and Medical Technology |
0 |
0.27 |
| Pandemic |
0 |
0.24 |
| Adjuvant Chemotherapy |
0 |
0.14 |
| Chemotherapy |
0 |
0.14 |
| Hospital |
0 |
0.14 |
| Medical Innovations |
0 |
0.14 |
| Surgery |
0 |
0.14 |
| Travel Medicine |
0 |
0.14 |
| Breast |
0 |
0.1 |
| Antigens |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Centers for Disease Control and Prevention |
0 |
0.05 |
| Child |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Face |
0 |
0.05 |
| Food and Drug Administration (FDA) |
0 |
0.05 |
| Immunization |
0 |
0.05 |
| Jobs |
0 |
0.05 |
| KRAS |
0 |
0.05 |
| Medical Life |
0 |
0.05 |
| Polymerase Chain Reaction |
0 |
0.05 |
| Professional Development |
0 |
0.05 |
| Radiation Therapy |
0 |
0.05 |
| Sarcoma |
0 |
0.05 |
| Stress |
0 |
0.05 |
| Telehealth and Telemedicine |
0 |
0.05 |
| Tumor |
0 |
0.05 |
| Vaccines |
0 |
0.05 |